Study of Positron Emission Tomography With 18-fluorodeoxyglucose in Detecting Cancer in Patients With Idiopathic Venous Thromboembolism
- Demonstrate the efficacy, in terms of increased numbers of cancer diagnoses, of PET-CT
with 18-FDG in patients with idiopathic venous thromboembolism.
- Assess the risk of cancer detected at 1 year.
- Assess whether PET allows earlier detection of cancer.
- Evaluate survival.
OUTLINE: This is a multicenter study.
All patients undergo standard (clinical and biological) diagnostic tests for cancer.
Patients are randomized to 1 of 2 diagnostic arms.
- Arm I: Patients undergo diagnostic fludeoxyglucose F 18 PET in addition to standard
- Arm II: Patients only undergo standard diagnostic methods. Patients are followed up for
Allocation: Randomized, Primary Purpose: Diagnostic
Number of cancers diagnosed
Pierre-Yves Salaun, MD
CHU Brest - Hopital De La Cavale Blanche